Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fatigue × Midazolam × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 15 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 9 Prostatic Neoplasms 4 Melanoma 4 Lung Neoplasms 4 Solid Tumor 3 Neoplasm Metastasis 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Glioma 2 Gastrointestinal Stromal Tumors 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Choledochal Cyst 2 Carcinoma 2 Anxiety Disorders 2 Advanced Solid Tumor 2 Advanced Malignancies 2 cMET-dysregulated Advanced Solid Tumors 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Terminal Cancer 1 Synovitis, Pigmented Villonodular 1 Solid Tumour 1 Solid Tumors, KRAS Mutation 1

Interventions

Therapeutics 27 Exercise 27 Modafinil 16 Yoga 15 Surveys and Questionnaires 14 Methylphenidate 14 Psychiatric Rehabilitation 11 Acupuncture Therapy 9 Educational Status 8 Cognitive Behavioral Therapy 8 Walking 7 Control Groups 7 Ultraviolet Therapy 6 Exercise Therapy 6 Early Intervention, Educational 6 Acceptance and Commitment Therapy 6 Therapeutic Touch 5 Physical Therapy Modalities 5 Mental Status and Dementia Tests 5 Counseling 5 Palliative Care 4 Methods 4 Epoetin Alfa 4 Dexamethasone 4 Behavior Therapy 4 Touch 3 Sugars 3 Standard of Care 3 Sodium Chloride 3 Saline Solution 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02317341 2019-03-20

Effect of Ketamine on Fatigue Following Cancer Therapy

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡